Reuters 
(5/16, Kelly) reports that St. Jude Medical Inc. has announced that it
has received a approval from European authorities to market its
EnligHTN Renal Denervation System which works to lower blood pressure
through renal denervation.
(5/16, Kelly) reports that St. Jude Medical Inc. has announced that it
has received a approval from European authorities to market its
EnligHTN Renal Denervation System which works to lower blood pressure
through renal denervation.
Bloomberg News
(5/16, Cortez) explains, "The EnligHTN system has multiple electrodes
on a catheter that is threaded into the kidney artery, allowing doctors
to ablate the nerves in an efficient and reliable manner, the company
said. The device can produce four ablations in 90 seconds, potentially
saving time, cutting costs and reducing the exposure to radiation."
(5/16, Cortez) explains, "The EnligHTN system has multiple electrodes
on a catheter that is threaded into the kidney artery, allowing doctors
to ablate the nerves in an efficient and reliable manner, the company
said. The device can produce four ablations in 90 seconds, potentially
saving time, cutting costs and reducing the exposure to radiation."
Trial Of 47 Patients Shows Drop In Systolic Blood Pressure.
Bloomberg News
(5/16, Cortez) that a "trial involving 47 patients found St. Jude's
EnligHTN device cut systolic blood pressure...by 28 millimeters of
mercury after 30 days." The trial results were "released today at
medical meeting EuroPCR in Paris."
(5/16, Cortez) that a "trial involving 47 patients found St. Jude's
EnligHTN device cut systolic blood pressure...by 28 millimeters of
mercury after 30 days." The trial results were "released today at
medical meeting EuroPCR in Paris."
Your post really helpful for my Renal Denervation Device Market Research and Development.
ReplyDelete